Uncategorized
Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia
American Journal of Obstetrics & Gynecology
Gestational diabetes early detection press
Clinical Advisor: Biomarker may ID gestational diabetes risk